European Urology published a clinical update in Research Highlights on 14 Jan 2026. The item focuses on Re: A Multicenter Randomized Phase II Trial of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Clear Cell RCC that Progressed on PD-1 Immune Checkpoint Inhibition (LenCabo). Review the original article for the full source wording and details.
European Urology published a clinical update in Research Highlights on 14 Jan 2026.
The item focuses on Re: A Multicenter Randomized Phase II Trial of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Clear Cell RCC that Progressed on PD-1 Immune Checkpoint Inhibition (LenCabo).
Review the original article for the full source wording and details.